Irina Kline

Irina Kline has held a variety of roles in the pharmaceutical industry since 1998. Irina began their career at Covance as a Therapeutic Research Associate. Irina then moved to Kyowa Pharmaceutical, Inc. in 2001 where they were a Clinical Trial Lead. In 2004, they joined Actelion Pharmaceuticals, Inc. as a Research Physician. Irina then moved to Transave Inc. in 2007 as a Medical Director. In 2010, they moved to Johnson & Johnson as a Clinical Lead, and in 2014 they joined Bristol-Myers Squibb as a Therapeutic Area Lead. Most recently, they have been appointed Executive Director at Fore Biotherapeutics, beginning in 2022.

Irina Kline attended Westminster International University in Tashkent from 1984 to 1990, where they obtained an MD in Medicine. Irina then attended Cardiff University / Prifysgol Caerdydd from 2004 to 2006, studying Pharmaceutical Medicine.